Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial

Author:

Gong Jessica1ORCID,Harris Katie1,Hackett Maree12,Peters Sanne A. E.134ORCID,Brodaty Henry56,Cooper Mark7,Hamet Pavel8,Harrap Stephen9,Mancia Giuseppe10,MacMahon Stephen13ORCID,Chalmers John1,Woodward Mark1311ORCID

Affiliation:

1. The George Institute for Global Health University of New South Wales Sydney New South Wales Australia

2. Faculty of Health and Wellbeing the University of Central Lancashire Lancashire UK

3. The George Institute for Global Health Imperial College London London UK

4. Julius Center for Health Sciences and Primary Care University Medical Center Utrecht, Utrecht University Utrecht the Netherlands

5. Centre for Healthy Brain Ageing, School of Psychiatry University of New South Wales Sydney New South Wales Australia

6. Dementia Centre for Research Collaboration University of New South Wales Sydney New South Wales Australia

7. Department of Diabetes, Central Clinical School Monash University Melbourne Victoria Australia

8. Montréal Diabetes Research Centre, Centre Hospitalier de l'Université de Montréal Quebec Montreal Canada

9. Royal Melbourne Hospital University of Melbourne Melbourne Victoria Australia

10. Policlinico di Monza and IRCCS Istituto Auxologico Italiano University of Milano‐Bicocca Milan Italy

11. Department of Epidemiology Johns Hopkins University Baltimore Maryland USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference68 articles.

1. Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia;Sastre AA;Cochrane Database of Systematic Reviews,2017

2. PrinceM WimoA GuerchetM AliG WuY PrinaM.Alzheimer's Disease International: World Alzheimer Report 2015: The Global Impact of Dementia: an Analysis of Prevalence Incidence Cost and Trends. London: Alzheimer's Disease International (ADI).2015.

3. Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities

4. Cognitive dysfunction in diabetes: how to implement emerging guidelines;Biessels GJ;Diabetologia.,2019

5. BMI, Weight Change, and Dementia Risk in Patients With New-Onset Type 2 Diabetes: A Nationwide Cohort Study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3